BMRA Live signaler | Maksimer profitt med Getagraph.com

SELG 122028 min ago

@ $0.940

Utstedt: 9 feb 2024 @ 20:05

Avkastning: -40.43%

Live Chart Being Loaded With Signals

Commentary (3 mai 2024 @ 22:00):

Stats
Dagens volum	260 910
Gjennomsnittsvolum	207 174
Markedsverdi	9.42M
EPS	$0 ( 2024-04-15 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.510
ATR14	$0.0140 (2.50%)

Insider Trading

Date	Person	Action	Amount	type
2023-12-13	Coste Catherine	Buy	75 000	Non-qualified stock option
2023-12-13	Moatazedi David	Buy	75 000	Non-qualified stock option
2023-12-13	Kenny John P.	Buy	75 000	Non-qualified stock option
2023-12-13	Emerson Jane	Buy	75 000	Non-qualified stock option
2023-12-13	Lu Gary	Buy	155 000	Non-qualified stock option

INSIDER POWER
100.00
Last 96 transactions
Buy: 2 712 565 \| Sell: 242 000

Volum Korrelasjon

Lang: -0.26 (neutral)

Kort: -0.63 (weak negative)

Signal:(50.66) Neutral

Biomerica Inc Korrelasjon

10 Mest positive korrelasjoner
AVGR	0.967
ARVL	0.967
FCBC	0.962
USEG	0.96
ISUN	0.959
ATNF	0.958
CMBM	0.957
SEV	0.957
PMVP	0.957
CAAS	0.956

10 Mest negative korrelasjoner
MLAI	-0.976
TCMD	-0.974
OXUS	-0.973
TZPS	-0.971
IPAR	-0.969
CBRG	-0.966
BIOT	-0.966
ORIA	-0.964
TZPSU	-0.963
BIOS	-0.962

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Biomerica Inc Korrelasjon - Valuta/Råvare

0.63
( weak )

0.74
( moderate )

0.00
( neutral )

0.80
( moderate )

0.00
( neutral )

-0.70
( moderate negative )

Biomerica Inc Økonomi

Annual	2023
Omsetning:	$5.34M
Bruttogevinst:	$446 000 (8.35 %)
EPS:	$-0.500

FY	2023
Omsetning:	$5.34M
Bruttogevinst:	$446 000 (8.35 %)
EPS:	$-0.500

FY	2022
Omsetning:	$18.87M
Bruttogevinst:	$2.98M (15.78 %)
EPS:	$-0.360

FY	2021
Omsetning:	$7.20M
Bruttogevinst:	$496 981 (6.90 %)
EPS:	$-0.540

Financial Reports:

No articles found.

Biomerica Inc

Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, or fecal specimens from patients in the diagnosis of various diseases and other medical complications; or to measure the level of specific bacteria, hormones, antibodies, antigens, or other substances, which exist in the patient's body and stools or blood in extremely small concentrations. It primarily sells its products for gastrointestinal diseases, food intolerances, diabetes, and various esoteric tests at the physicians' offices and over-the-counter drugstores, and hospital/clinical laboratories. The company is also developing InFoods, an irritable bowel syndrome therapy technology and diagnostic-guided therapy; Helicobacter pylori products, as well as develops, tests, validates, and sells diagnostic products for COVID-19 infection. Biomerica, Inc. was incorporated in 1971 and is headquartered in Irvine, California.